What constitutes adequate medical therapy for the patient with angina pectoris?
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy / Q000628:therapy*; D001161:Arteriosclerosis / Q000517:prevention & control; D003692:Delayed-Action Preparations; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D004897:Erythrityl Tetranitrate / Q000627:therapeutic use; D005080:Exercise Test; D006339:Heart Rate / Q000187:drug effects; D006760:Hospitalization; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000517:prevention & control; D005996:Nitroglycerin / Q000627:therapeutic use; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D004897:Erythrityl Tetranitrate; D011433:Propranolol; D005996:Nitroglycerin; D007548:Isosorbide Dinitrate